• Amyloid β-Peptide (1-42): Assay Workflows

  2026-08-26

  Build reproducible Aβ42 peptide workflows for aggregation imaging, neuronal toxicity, and ion-channel studies. This guide connects fresh peptide handling with ratiometric fibril detection and practical troubleshooting for Alzheimer’s disease research.

• X-press Tag Peptide for RHEB Assays

  2026-08-26

  Use the X-press Tag Peptide as a three-in-one handle for affinity capture, Anti-Xpress antibody detection, and controlled enterokinase release. This workflow is especially useful for producing and comparing RHEB variants when investigating the UBE2F–SAG–RHEB–mTORC1 signaling axis.

• Pregnenolone Carbonitrile Beyond Canonical PXR

  2026-08-25

  Pregnenolone Carbonitrile is more than a rodent PXR agonist for xenobiotic metabolism research. This thought-leadership analysis examines its tissue-specific CYP response, antifibrotic potential, formulation considerations, and translational value as a mechanistic probe rather than a simple induction control.

• ATRX-Deficient Glioma and RTK Inhibitor Sensitivity

  2026-08-25

  Pladevall-Morera et al. show that ATRX-deficient high-grade glioma cells are more vulnerable to multi-targeted RTK and PDGFR inhibitors than ATRX-proficient models. The study also reports pronounced toxicity when selected inhibitors are combined with Temozolomide, supporting ATRX status as a useful variable for glioma pharmacology and clinical-trial interpretation.

• Bestatin (Ubenimex): Aminopeptidase Assay Guide

  2026-08-24

  Bestatin (Ubenimex) is a selective aminopeptidase perturbation tool for connecting enzyme activity with cell phenotypes, multidrug resistance, and signaling responses. This guide converts its inhibition profile into practical workflows for aminopeptidase activity measurement, apoptosis assay design, cancer research, and plant chemical genetics.

• RIPA Lysis Buffer (Strong) for BBB Protein Studies

  2026-08-24

  Build reproducible lysates from astrocytes, brain endothelial cells, co-cultures, and animal tissues for pathway-focused protein analysis. This workflow shows how strong detergent chemistry supports Western blotting, ELISA, and carefully controlled immunoprecipitation while preserving practical options for troubleshooting.

• N-MYC–eIF4G1 Survival Axis in inv(16) AML

  2026-08-23

  Peramangalam et al. identify an N-MYC-driven survival program in inv(16) acute myeloid leukemia, centered on a previously unrecognized MYCN enhancer and the translation factor eIF4G1. The study connects disruption of CBFβ-SMMHC–RUNX1 signaling with MYCN repression and provides a mechanistic framework for investigating leukemia maintenance in cellular and patient-derived models.

• TTP, m6A, and Liver Fibrosis in Schistosomiasis

  2026-08-22

  The reference study identifies tristetraprolin as an anti-fibrotic regulator that promotes WTAP transcription through SMAD2/3 and alters TGF-β1 mRNA stability through m6A modification. Its integrated genetic, transcriptomic, epitranscriptomic, and proteomic design provides a framework for testing how RNA methylation controls hepatic stellate cell activation during Schistosoma japonicum infection.

• LY2886721 Workflow for BACE1 Research

  2026-08-22

  LY2886721 supports controlled BACE1 enzyme inhibition across cellular, neuronal, biomarker, and oral in vivo workflows. Its strongest use-case is dose-calibrated amyloid beta reduction paired with synaptic-function monitoring, helping researchers distinguish pathway engagement from excessive physiological disruption.

• Live-Dead Cell Staining Kit I for Ferroptosis

  2026-08-21

  Discover how the Live-Dead Cell Staining Kit I (Calcein AM/PI) can strengthen mammalian cell viability assay design in ferroptosis research. This article focuses on interpreting membrane integrity, esterase activity, and mechanistic evidence without mistaking a viability endpoint for proof of cell-death identity.

• Pemetrexed: From Folate Stress to Assay Design

  2026-08-20

  Pemetrexed is more than a broad antifolate: it is a practical probe for separating nucleotide stress from DNA-repair vulnerability. This guide integrates pemetrexed disodium chemistry, malignant mesothelioma evidence, and assay-design decisions for translational cancer research.

• Atorvastatin: From Mevalonate to Ferroptosis

  2026-08-20

  Atorvastatin is an HMG-CoA reductase inhibitor that links mevalonate biology with vascular signaling and ferroptosis research. This guide explains how to translate that multi-pathway profile into better assay design, controls, and interpretation.

• Solanesol B8776: Handling and Assay Workflow Guide

  2026-08-19

  Solanesol B8776 provides a defined polyisoprenoid alcohol for hydrophobic biochemical workflows, including membrane-related experiments and selected enzyme or cell-based assays. Its limited solvent compatibility means it should be prepared in DMSO, handled as a fresh solution when possible, and excluded from water- or ethanol-based systems and from diagnostic or medical use.

• 3D Organoid–Fibroblast Models of PDAC Chemoresistance

  2026-08-19

  Schuth et al. developed a patient-matched three-dimensional co-culture system combining pancreatic ductal adenocarcinoma organoids with cancer-associated fibroblasts. The model revealed that fibroblasts increase organoid proliferation, reduce chemotherapy-induced cell death, and promote transcriptional programs associated with inflammation and epithelial-to-mesenchymal transition, providing a more physiologically informative platform for personalized drug-response research.

• VX-745: Practical p38α MAPK Inhibition

  2026-08-18

  VX-745 combines nanomolar p38α selectivity with practical workflows for cytokine, cancer, aging, and arthritis research. This guide connects pathway inhibition to phosphatase-aware assay design, helping researchers distinguish direct signaling effects from formulation, timing, and cell-context artifacts.

8023 records 1/535 page Next 12345 下5页 Last page